Methylene blue: Difference between revisions
No edit summary |
No edit summary |
||
Line 28: | Line 28: | ||
| ImageSize1 = | | ImageSize1 = | ||
| ImageName1 = Space-filling model of methylene blue in its oxidised form | | ImageName1 = Space-filling model of methylene blue in its oxidised form | ||
| IUPACName = 3,7-bis(Dimethylamino) | | IUPACName = 3,7-bis(Dimethylamino)phenothiazin-5-ium chloride | ||
| OtherNames = C.I. 52015 | | OtherNames = C.I. 52015 | ||
|Section1={{Chembox Identifiers | |Section1={{Chembox Identifiers |
Revision as of 19:48, 22 April 2015
{{DrugProjectFormSinglePage |genericName=Methylene blue |indicationType=treatment |indication=Drug induced methemoglobinemia |blackBoxWarningTitle=TITLE |blackBoxWarningBody=Condition Name: (Content) |fdaLIADAdult====Indications=== Drug induced methemoglobinemia
Dosage
0.1 to 0.2 mL per kilogram of body weight (0.045 to 0.09 mL per pound of body weight). Inject Methylene Blue intravenously very slowly over a period of several minutes. |offLabelAdultGuideSupport=There is limited information regarding Off-Label Guideline-Supported Use of Methylene blue in adult patients. |offLabelAdultNoGuideSupport=There is limited information regarding Off-Label Non–Guideline-Supported Use of Methylene blue in adult patients. |offLabelPedGuideSupport=There is limited information regarding Off-Label Guideline-Supported Use of Methylene blue in pediatric patients. |offLabelPedNoGuideSupport=There is limited information regarding Off-Label Non–Guideline-Supported Use of Methylene blue in pediatric patients. |contraindications=Intraspinal injection is contraindicated. |warnings=Methylene Blue should not be given by subcutaneous or intrathecal injection. |clinicalTrials=Large intravenous doses of Methylene Blue produce nausea, abdominal and precordial pain, dizziness, headache, profuse sweating, mental confusion and the formation of methemoglobin. |useInPregnancyFDA=Safety for use in pregnancy has not been established. Use of Methylene Blue in women of childbearing potential requires that anticipated benefits be weighed against possible hazards. |drugBox=
Template:Chembox E numberNames | |
---|---|
IUPAC name
3,7-bis(Dimethylamino)phenothiazin-5-ium chloride
| |
Other names
C.I. 52015
| |
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
PubChem CID
|
|
UNII | |
| |
| |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |